GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 81 filers reported holding GLYCOMIMETICS INC in Q4 2017. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $60,000 | -97.3% | 15,800 | -88.7% | 0.00% | -99.2% |
| Q2 2018 | $2,258,000 | -41.9% | 140,000 | -41.6% | 0.12% | -58.2% |
| Q1 2018 | $3,889,000 | -48.5% | 239,575 | -46.8% | 0.29% | -52.8% |
| Q4 2017 | $7,556,000 | +8.0% | 450,000 | -10.0% | 0.62% | -3.1% |
| Q3 2017 | $6,996,000 | +15.9% | 500,104 | -7.6% | 0.64% | +2.7% |
| Q2 2017 | $6,038,000 | – | 541,034 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,361,801 | $31,729,000 | 3.33% |
| NEA Management Company, LLC | 9,089,041 | $39,174,000 | 3.24% |
| Camber Capital Management LP | 3,500,000 | $15,085,000 | 0.79% |
| Redmile Group, LLC | 1,997,647 | $8,610,000 | 0.29% |
| Alambic Investment Management, L.P. | 41,698 | $180,000 | 0.14% |
| CAXTON CORP | 26,575 | $115,000 | 0.13% |
| PRENTISS SMITH & CO INC | 17,000 | $73,000 | 0.05% |
| Virtus ETF Advisers LLC | 22,580 | $97,000 | 0.02% |
| AXA S.A. | 1,825,738 | $7,868,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 30,000 | $129,000 | 0.01% |